Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Innate Pharma SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

INNATE PHARMA MARSEILLE (IPHYF=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

29 Oct 2016 Pechala's Reports 2 $25.00

Innate Pharma SA: Downgraded to Below Average

21 Oct 2016 Sadif Analytics Prime 3 $10.00

Innate Pharma S.A. (IPH) - Financial Analysis Review

Innate Pharma S.A. (IPH) - Financial Analysis Review Summary Innate Pharma S.A. (Innate Pharma) is a bio-pharmaceutical compa...

14 Oct 2016 GlobalData 48 $300.00

Wright Investors Service Comprehensive Report for Innate Pharma S.A.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

03 Oct 2016 Wright Reports 65 $75.00

Innate Pharma S.A. (IPH) - Financial Analysis Review

Innate Pharma S.A. (IPH) - Financial Analysis Review Summary Innate Pharma S.A. (Innate Pharma) is a bio-pharmaceutical compa...

12 Sep 2016 GlobalData 44 $300.00

Is Innate Pharma SA Share Price Sustainable?

15 Aug 2016 Sadif Analytics Prime 11 $25.00

Innate Pharma SA: Downgraded to Average

09 Aug 2016 Sadif Analytics Prime 3 $10.00

Innate Pharma S.A. (IPH) - Financial Analysis Review

Innate Pharma S.A. (IPH) - Financial Analysis Review Summary Innate Pharma S.A. (Innate Pharma) is a bio-pharmaceutical compa...

17 Jun 2016 GlobalData 46 $300.00

Innate Pharma SA: Upgraded to Good

02 Jun 2016 Sadif Analytics Prime 3 $10.00